2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Relapsing Forms of Multiple Sclerosis: new trials by email Literature Review of Relapsing Forms of Multiple Sclerosis trials Research Report on Relapsing Forms of Multiple Sclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS) BIIB091, DRF, Placebo - Relapsing Forms of Multiple Sclerosis | Phase 2 | Completed | Biogen | 127 | 2023-07-25 | 2026-02-20 |
| Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis. dimethyl fumarate, tetanus diphtheria toxoids vaccine, 23-valent pneumococcal polysaccharide vaccine - Relapsing Forms of Multiple Sclerosis | Phase 2 | Completed | Biogen | 71 | 2015-02-28 | 2017-06-02 |
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Immune System Diseases (1) · Nervous System Diseases (1)
23-valent pneumococcal capsular polysaccharide vaccine (1) · BIIB091 (1) · Dimethyl Fumarate (1) · Diphtheria-Tetanus Vaccine (1) · Meningococcal Vaccines (1)
Biogen (2)
United States (2) · Bulgaria (1) · Czechia (1) · Germany (1) · Italy (1) · Poland (1) · Puerto Rico (1) · Romania (1) · Spain (1) · Switzerland (1)